Progyny's Q4 2023 saw a 26% increase in revenue, gross margin expansion by 30 basis points, and a near quadrupling of net income. The company exceeded $1 billion in annual revenue for the first time in 2023, with cash flow from operations more than doubling.
Revenue increased by 26% compared to Q4 2022, reaching $269.9 million.
Gross margin expanded by 30 basis points compared to the prior year period.
Net income nearly quadrupled compared to Q4 2022, reaching $13.5 million.
Adjusted EBITDA increased by 31% compared to Q4 2022, reaching $43.2 million.
Progyny anticipates having more than 460 clients, representing an estimated 6.7 million covered lives in 2024. The company projects revenue between $1.285 billion and $1.315 billion for full year 2024.
Visualization of income flow from segment revenue to net income